Search Results - Kantarjian

Refine Results
  1. 1
    Acute myeloid leukemia—Major progress over four decades and glimpses into the future

    Acute myeloid leukemia—Major progress over four decades and glimpses into the future by Hagop Kantarjian

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Honoring Emil J. Freireich: A Visionary Medical Cancer Researcher—March 21, 1927–February 1, 2021

    Honoring Emil J. Freireich: A Visionary Medical Cancer Researcher—March 21, 1927–February 1, 2021 by Kantarjian, Hagop M.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients

    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients by Andreas Hochhaus, Hagop Kantarjian

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients

    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients by Hochhaus, Andreas, Kantarjian, Hagop

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    How I treat newly diagnosed chronic phase CML

    How I treat newly diagnosed chronic phase CML by Cortes, Jorge, Kantarjian, Hagop

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy

    Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy by Kantarjian, Hagop, Cortes, Jorge

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    TARGETED THERAPY: Generic imatinib — impact on frontline and salvage therapy for CML

    TARGETED THERAPY: Generic imatinib — impact on frontline and salvage therapy for CML by Gorkin, Larry, Kantarjian, Hagop

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies

    Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies by Jabbour, Elias, Kantarjian, Hagop

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Chronic myeloid leukemia: sequencing of TKI therapies

    Chronic myeloid leukemia: sequencing of TKI therapies by Cortes, Jorge, Kantarjian, Hagop

    Published 2016
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Core binding factor acute myelogenous leukemia-2021 treatment algorithm

    Core binding factor acute myelogenous leukemia-2021 treatment algorithm by Borthakur, Gautam, Kantarjian, Hagop

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Acute lymphoblastic leukemia a comprehensive review with emphasis on biology and therapy

    Acute lymphoblastic leukemia a comprehensive review with emphasis on biology and therapy by Jorge E. Cortés, H. Kantarjian

    Published 1995
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring

    Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring by Elias Jabbour, Hagop M. Kantarjian

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring

    Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring by Elias Jabbour, Hagop M. Kantarjian

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Core binding factor acute myelogenous leukemia-2021 treatment algorithm

    Core binding factor acute myelogenous leukemia-2021 treatment algorithm by Gautam Borthakur, Hagop M. Kantarjian

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Moving toward individualized target-based therapies in acute myeloid leukemia

    Moving toward individualized target-based therapies in acute myeloid leukemia by Alexandre Bazinet, Hagop M. Kantarjian

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring

    Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring by Elias Jabbour, Hagop M. Kantarjian

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era

    When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era by Short, Nicholas J., Kantarjian, Hagop

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    How I treat newly diagnosed chronic phase CML

    How I treat newly diagnosed chronic phase CML by Jorge E. Cortés, Hagop M. Kantarjian

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Impact of Cancer Research Bureaucracy on Innovation, Costs, and Patient Care

    Impact of Cancer Research Bureaucracy on Innovation, Costs, and Patient Care by David P. Steensma, Hagop M. Kantarjian

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Navigating the Management of Chronic Phase CML in the Era of Generic BCR::ABL1 Tyrosine Kinase Inhibitors

    Navigating the Management of Chronic Phase CML in the Era of Generic BCR::ABL1 Tyrosine Kinase Inhibitors by Fadi G. Haddad, Hagop M. Kantarjian

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: